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Comparison of Thyroid Blood Flow and Uptake Indices Using 
Technetium-99m Pertechnetate in Patients with Graves’ Disease and 
Euthyroid Subjects
Graves’ Hastalığı olan Hastalarda ve Ötiroid Kişilerde Teknesyum 99m Perteknetat ile Tiroid 
Kan Akımı ve Uptake İndekslerinin Karşılaştırılması
Abstract
Objective: The aim of the present study was to evaluate parameters of early blood flow (EBF) including duration of EBF, perfusion 
index (PI), uptake indexes 1 and 2 (UI1 and UI2) derived from dynamic thyroid scintigraphy in patients with Graves’ disease (GD), and 
euthyroid (EI). Maximum instant uptake and maximum uptake of the thyroid gland were also assessed.
Methods: A total of 50 patients with GD and EI were included in this study. Each patient underwent two dynamic scans of 1-minute 
(20 images at 3 seconds) and 20-minute (20 images at 1 minute) with 99mTcO4. The time-activity curve of a 1-minute scan was 
employed to derive EBF parameters; likewise, the time-activity curve of a 20-minute scan was used to determine maximum instant 
uptake, and the gradient of the curve from the 10th to 20th minute was used to assess maximum uptake.
Results: Values of EBF duration, PI, UI1, UI2, and maximum instant uptake were significantly lower in patients with GD than in 
those with EI (p<0.05). The calculated gradient of the second half of the curves for all of the patients ranged from 0 to 0.88 and was 
significantly higher in patients with GD than in those with EI.
Conclusion: Lower values of PI, UI1, UI2 and durations of EBF, along with faster maximum instant uptake in patients with GD in 
comparison to EI are indicators of a heightened desire for hyper-functioning thyroid glands of patients with GD to absorb 99mTcO4. 
Additionally, because of the uprising gradient at the end of the 20-minute time-activity curve, a maximum thyroid uptake of 99mTcO4 
was achieved at more than 20 minutes after the radiopharmaceutical injection.
Key words: Regional blood flow, radionuclide imaging, perfusion imaging, Graves’ disease
Özet
Amaç: Bu çalışmanın amacı Graves’ hastalığı (GH) olan hastalarda ve ötiroid (Ö) kişilerde yapılan dinamik tiroid sintigrafisinden elde 
edilen en kan akımı (EKA) süresi, perfüzyon indeksi (PI), uptake indeksi 1 ve 2 (UI1 ve UI2) gibi erken kan akımı parametrelerinin 
değerlendirilmesi idi. Tiroid bezinin maksimum uptake ve maksimum anlık uptake de araştırıldı. 
Yöntem: GH ve Ö olan toplam 50 hasta çalışmaya dahil edildi. Her hastaya 99mTcO4 ile 1 dakikalık (3 saniyelik 20 görüntü) ve 
20 dakikalık (1 dakikalık 20 görüntü) iki dinamik görüntüleme yapıldı. Bir dakikalık görüntülemenin zaman aktivite eğrisi EKA 
parametrelerini, 20 dakikalık görüntülemenin zaman aktivite eğrisi de maksimum anlık uptake değerini, 10-20 dakika arasındaki eğrinin 
eğimi ise maksimum uptake değerini hesaplamada kullanıldı.
Bulgular: EKA süresi, PI, UI1, UI2 ve maksimum anlık uptake değerleri, GH olan hastalarda Ö hastalara göre anlamlı olarak daha 
düşüktü (p<0,05). Eğrinin ikinci yarısının hesaplanan eğimi tüm hastalarda 0 ile 0,88 arasında değişiyordu ve GH olan hastalarda Ö 
hastalara göre anlamlı olarak daha yüksekti.
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Introduction
Various types of thyroid disorders may affect normal 
function of the thyroid glands. For instance, in Graves’ 
disease, thyroid stimulating hormone receptor antibodies 
(TSHR-Ab) bind thyroid stimulating hormone receptor (TSHR) 
and activate it, leading to hyper-secretion, hypertrophy, and 
hyperplasia of the thyroid follicles (1). One of the features 
of this interruption may appear in thyroid blood flow 
(2,3,4,5,6). Therefore, evaluation of this parameter may be 
an indicator in assessment of thyroid gland function.
A number of methods have been introduced and 
employed to assess thyroid blood flow including angiography, 
electromagnetic flowmetry, doppler ultrasonography, and 
nuclear medicine imaging. Because of problems associated 
with the invasiveness of angiography and electromagnetic 
flowmetry, these methods are not commonly utilized; 
however, application of ultrasonography for this purpose 
benefits from simplicity, noninvasiveness, and the potential 
for quick differentiation between diffuse and nodular 
thyroid disease (7,8,9,10). Application of diagnostic nuclear 
medicine techniques for this purpose-thyroid scintigraphy-
is associated with favorable sensitivity and specificity 
which provides images of the vascularity of “cold” thyroid 
nodules, which can be used to distinguish neoplastic from 
non-neoplastic ones (8,11,12,13). Because of the similarity 
of the 99mTcO4 with iodine (with respect to the molecular 
size), thyroid uptake of 99mTc can be used to assess thyroid 
function (14).
It is accepted that the maximum thyroid uptake from 
99mTcO4 is usually achieved at 10 to 20 minutes after 
intravenous injection of the radiotracer. As maximum 
thyroid uptake of the radiopharmaceutical is necessary to 
the proper evaluation of thyroid function, the 20-minute 
thyroid uptake is commonly used to estimate thyroid 
function (15,16,17).
The aim of the present study was to assess and compare 
parameters of EBF derived from dynamic thyroid scintigraphy 
in patients with GD and EI. Also, maximum instant uptake 
of 99mTc uptake over 20 minutes was determined and 
compared for all patients with GD and EI. We assessed 
whether scintigraphy of the thyroid at 20 minutes after 
intravenous injection of 99mTc provides the required time 
for maximum uptake of radiopharmaceuticals.
Materials and Methods
A total of 50 patients with GD (37) and EI (13) were 
included in this prospective study. Diagnosis of the disease 
was based on clinical and laboratory findings. In their 
documents, patients with GD experienced symptoms 
such as hyperthyroidism and elevated levels of thyroid 
hormones. In the documents of the EI, no symptoms of 
hyperthyroidism were observed and levels of TT3, TT4, and 
TSH were normal.
Following the intravenous injection 5 mCi 99mTcO4 as a 
bolus, thyroid scintigraphy of each patient was performed in 
the supine position with neck extended. A gamma camera 
(ADAC Pegasys; model SH Genesys Epic) was positioned 
7 cm over the thyroid gland. For each patient, dynamic 
scintigraphy was performed in two steps: first, in order 
to study perfusion of the thyroid gland, each patient was 
scanned over 1 minute as 20 frames of 3 seconds; second, 
in order to assess thyroid uptake, each patient was scanned 
over 20 minutes as 20 frames of 1 minute. Results of the 
scans were recorded on a 64×64 matrix using a zoom 
factor of 1.5.
Time-activity curves of the patients were generated 
following the background subtraction. In order to do this, 
one region of interest (ROI) was drawn around the thyroid 
gland to be used to determine thyroid activity while another 
ROI was drawn below the gland to be used to determine 
background activity.
Parameters of thyroid blood flow were derived from 
time-activity curves similar to the method applied by Sekulic 
et al. (14) as follows:
EBF duration, which is the interval time between the 
start and the end of EBF curve; the perfusion index, which 
is the ratio of counts at the beginning of the EBF to the 
counts at the end of the EBF; the uptake index 1, which is 
the ratio of the counts at the end of EBF to the counts at 
the 60th seconds; and the uptake index 2, which is the ratio 
of the counts at the 30th seconds to the counts at the 60th 
seconds (Figure 1).
In order to assess if scintigraphy of the thyroid at 
the 20th minute after intravenous injection of 99mTcO4 
provides the required time for maximum uptake of the 
radiopharmaceutical, in a time-activity curve, the gradient 
of the line fitted to the second 10 minutes of the curve 
(from 10th to 20th minutes) was determined. Also, the 
time point during the 20-minute scans in which the highest 
amount of 99mTcO4 uptake would occur (maximum instant 
uptake) was determined for all patients with GD and EI 
(Figure 2).
Statistical Analysis
In each case, the curves were acquired utilizing the 
Analysis ToolPak added to Microsoft Excel. All obtained 
data were provided with mean ± SE, minimum, and 
Sonuç: Ö hastalarla karşılaştırıldığında, GH hastalarında PI, UI1, UI2 ve EKA süresinin düşüklüğü hızlı maksimum anlık uptake ile 
birlikte, hiperfonksiyone tiroid bezinin 99mTcO4’ü absorbe etmekteki artmış isteğini gösterir. Ayrıca 20 dakikalık zaman aktivite eğrisinin 
sonundaki artmış eğim sebebiyle, 99mTcO4’ün maksimum tiroid uptake’ine radyofarmasötik enjeksiyonundan 20 dakikadan daha 
sonra ulaşılmaktadır.
Anahtar kelimeler: Bölgesel kan akımı, radyonüklid görüntüleme, perfüzyon görüntüleme, Graves’ hastalığı
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maximum values. Comparison of data between GD and EI 
was performed using a Mann-Whitney U test. A p value of 
less than 0.05 was considered statistically significant. SPSS 
for Windows software package (Release 18, SPSS Inc., 
Chicago, Illinois) was used for the statistical analysis.
Results
All of the patients with GD and EI underwent dynamic 
thyroid scintigraphy with 99mTcO4. After the background 
subtraction, recorded activities were used to generate 
corresponding time-activity curves of the 1-minute and 
20-minute scans.
The 1-minute time-activity curves were used to extract 
semi-quantitative parameters of thyroid uptake of 99mTcO4. 
A summary of the resulting data is presented in Table 1. As 
shown in the table, duration of EBF in the 1-minute time-
activity curve was significantly lower in patients with GD in 
comparison to those with EI (p<0.05). It was also observed 
that UI1 and UI2 in patients with GD were significantly 
faster than in EI (p<0.05). The difference in PI between 
patients with GD and EI was also significant (p<0.05).
In the 20-minute time-activity curves, maximum instant 
gradient during 20 minutes for patients with GD and EI 
were determined as 4.30 and 5.54 minutes, respectively. 
According to the corresponding data, the time required for 
the thyroid to reach maximum instant gradient in patients 
with GD was significantly shorter than in those with EI 
(p<0.05).
The gradient of the best-fit line to the curve from the 
10th to 20th minute was calculated respectively as 0.125 
and 0.0043 for the patients with GD and EI, indicating a 
statistically significant difference between the two groups 
(p<0.05) (Table 2).
Discussion
In previous studies, it was found by ultrasonography 
that thyroid vascularity-and therefore thyroid blood flow-
increased in patients with hyperthyroidism (5). In addition, 
TSH is able to stimulate the expression of growth factors in 
thyroid follicular cells, which in turn results in the synthesis 
of endothelium. One of the consequences observed 
following the synthesis of endothelium is blood capillary 
enlargement and a resulting increase in thyroid blood flow. 
In patients with GD, a similar process may occur with TSHR-
Ab (18). Therefore, further study of the thyroid blood flow 
may provide vital information for these patients.
Evaluation of the vascularity of thyroid glands with 
99mTcO4 scintigraphy has been reported in many studies 
(8,12,19,20). As a consequence of vascularity, concentration 
of radioactivity has been increased in the thyroid gland of 
patients with GD.
In the present study, results of 1-minute dynamic 
scans which were performed to semi-quantitatively assess 
parameters of thyroid blood flow and uptake of 99mTcO4, 
revealed that duration of early blood flow in patients with 
GD is significantly shorter than in those with EI (p<0.05). It 
was also found that uptake index 1 and 2 in patients with GD 
is faster than in those with EI, and the observed difference 
was statistically significant (p<0.05). These findings related 
to the increased vascularity and hyper-functioning thyroid 
glands in patients with GD were consistent with the results 
of a similar study performed by Sekulic et al. (14). However, 
in our study the perfusion index (PI) was smaller in patients 
with GD than in those with EI; therefore our study was 
not completely concordant with the results of the study 
performed by Sekulic et al. may be due to small numbers 
in both studies and also different included population in 
each study which may be due to small sample size and also 
different included population in each study.
As indicated in the literature and guidelines, thyroid 
glands achieve maximum uptake 20 minutes after the 
injection of 99mTcO4. For this reason, thyroid static scans 
are routinely performed following this period of time to 
estimate thyroid function. In this study, 20-minute dynamic 
scans of the thyroid uptake provided an opportunity to 
assess maximum thyroid uptake semi-quantitatively. Analysis 
Figure 1. Typical 1-minute time-activity curve (time in seconds)
Figure 2. Typical 20-minute time activity curve (time in minutes)
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of the equation of the best line fitted to the second half 
(from 10th to 20th minutes) of each generated time-activity 
curve indicated that, in the majority of patients with GD 
and EI, gradients of these lines were not zero and extended 
up to 0.88. The greater the gradient of the fitted line to the 
time-activity curve, the greater the tendency of the thyroid 
gland to reach its maximum uptake after 20 minutes. On 
the other hand, this semi-quantitative analysis indicated that 
static scintigraphy of the thyroid gland 20 minutes after the 
injection of 99mTcO4 might not accurately estimate thyroid 
function, and that a longer time interval might provide 
more reliable information. Comparison of the mean values 
of these gradients in patients with GD and EI revealed that 
this quantity is significantly higher in patients with GD than 
in those with EI. This means that patients with GD require 
much longer times than those with EI in order for maximum 
uptake to be achieved.
Based on analysis of the gradients of the time-activity 
curve in each of 20 scans taken over 20 minutes (20 
gradients for each curve), we also found that maximum 
instant uptake (among the 20 gradients for each curve) 
of thyroid gland occurs more quickly in patients with GD 
than in those with EI. The reason for our findings regarding 
maximum uptake and maximum instant uptake of thyroid 
might be related to the function of thyroid glands in 
patients with GD, in which the malfunctioned gland has 
more desire to absorb and keep 99mTcO4 in the earlier 
moments after the injection of the radiopharmaceutical 
and tends to absorb it for a longer time.
Conclusion
Thyroid glands of patients with GD, in comparison with 
those found in patients with EI, demonstrate faster UI1 and 
UI2, and maximum instant uptake occurs faster. In order 
to obtain more reliable statistical scans of thyroid glands 
with 99mTcO4, we recommend that a duration longer 
than 20 minutes be considered between injection of the 
radiopharmaceutical and performance of the scintigraphy. 
However, further studies investigating dynamic scans of 
the thyroid gland at intervals greater than 20 minutes are 
recommended to support such an assumption.
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